Precigen
PGEN
173 hedge funds and large institutions have $3.23B invested in Precigen in 2015 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 34 closing their positions.
1.8% more ownership
Funds ownership: 87.57% → 89.37% (+1.8%)
3% more call options, than puts
Call options by funds: $39.1M | Put options by funds: $37.8M
0% more funds holding
Funds holding: 173 → 173 (0)
0% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 34
3% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 62
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
30% less capital invested
Capital invested by funds: $4.63B → $3.23B (-$1.4B)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$256M |
| 2 |
Morgan Stanley
New York
|
+$94M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$75.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$25.2M |
Top Sellers
PGEN Hedge Fund Activity: Q3 2015 in Review
173 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2015, worth a combined $3.23B — down 30% from $4.63B a quarter earlier.
Fund positioning in PGEN was balanced in Q3 2015: 34 funds opened new positions, 34 closed out, 60 added to existing stakes and 62 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $256M. The largest seller was Third Point, cutting an estimated $59.1M.
- 173 institutional investors held Precigen (PGEN) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $3.23B of Precigen stock for Q3 2015, down 30% quarter-over-quarter.
- 34 funds opened new Precigen positions in Q3 2015 and 34 closed out, a net change of 0 holders.
- The largest Precigen buyer in Q3 2015 was Fidelity Investments, an estimated $256M added.
- The largest Precigen seller in Q3 2015 was Third Point, an estimated $59.1M sold.
Based on aggregated 13F filings for Q3 2015.